90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years

Benutzer: Gast

Titel:: 90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years
Dokumenttyp:: Zeitschriftenaufsatz
Autor(en):: Rieger, Kathrin; De Filippi, Rosaria; Lindén, Ola; Viardot, Andreas; Hess, Georg; Lerch, Kristina; Neumeister, Peter; Stroux, Andrea; Peuker, Caroline A.; Pezzutto, Antonio; Pinto, Antonello; Keller, Ulrich; Scholz, Christian W.
Zeitschriftentitel:: Annals of Hematology
Jahr:: 2022
Band / Volume:: 101
Heft / Issue:: 4
Seitenangaben Beitrag:: 781-788
Volltext / DOI:: doi:10.1007/s00277-022-04781-3
Verlag / Institution:: Springer Science and Business Media LLC
E-ISSN:: 0939-55551432-0584
Publikationsdatum:: 12.02.2022
BibTeX

Vorkommen: